Colorectal tumor cells appear to lose the ability to produce AtRA [82] while, at the same time, they appear to increase AtRA degradation via the cytochrome P450 enzyme (CYP26A1), a major retinoic acid catabolic enzyme [83, 84]. This evidence concerns the gene CYP26A1 and colorectal neoplasm.